share_log

Dianthus Therapeutics Analyst Ratings

Benzinga ·  Sep 28, 2023 21:12
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
09/28/2023 80.32% Raymond James → $24 Initiates Coverage On → Outperform

What is the target price for Dianthus Therapeutics (DNTH)?

There is no price target for Dianthus Therapeutics

What is the most recent analyst rating for Dianthus Therapeutics (DNTH)?

There is no analyst for Dianthus Therapeutics

When is the next analyst rating going to be posted or updated for Dianthus Therapeutics (DNTH)?

There is no next analyst rating for Dianthus Therapeutics

Is the Analyst Rating Dianthus Therapeutics (DNTH) correct?

There is no next analyst rating for Dianthus Therapeutics

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment